Citigroup »

Alaunos Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Alaunos Therapeutics (TCRT) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Alaunos Therapeutics

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.00130323,032.530333,033.5303415961,596.515971,597.51598
Value ($)Share countHistorical TCRT position of Citigroup Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.0k 1.6k 1.90

More positions owned by Citigroup

Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Spdr Gold Tr Gold Shs (GLD)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Indl (XLI)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial (XLF)

View all positions for Citigroup

Top funds holding Alaunos Therapeutics

BlackRock
Vanguard Group
Geode Capital Management
UBS Group
Citigroup
Tower Research Capital
Morgan Stanley
Advisor Group Holdings
Bnp Paribas Arbitrage, Snc
Group One Trading
Atlantic Trust
Wells Fargo & Company
Sugarloaf Wealth Management
Bank of America Corporation
Royal Bank of Canada

View all funds holding Alaunos Therapeutics